Synthesis and in Vitro Pharmacology of Substituted Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate Transport

Por um escritor misterioso
Last updated 22 março 2025
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Richard J. Bridges's research works University of Montana, Missoula (UMT) and other places
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Christina N Carrigan's research works University of Montana, Missoula (UMT) and other places
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Biomolecules, Free Full-Text
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system xc- - ScienceDirect
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs - ScienceDirect
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Modulation of Hippocampal Synaptic Transmission by the Kynurenine Pathway Member Xanthurenic Acid and Other VGLUT Inhibitors
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
US8802853B2 - Arylalkenyl and arylalkynyl substituted imidazoquinolines - Google Patents
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Visible-light-induced and copper-catalyzed oxidative cyclization of substituted o -aminophenylacetylene for the synthesis of quinoline and indole deri - Organic Chemistry Frontiers (RSC Publishing) DOI:10.1039/D1QO00914A
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Frontiers Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist
Dimethyl 2-Ketoglutaconate (CAS 13192-04-6)
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Dimethyl 2-Ketoglutaconate | CAS 13192-04-6
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Discovery of Novel 2,5-Dioxoimidazolidine-Based P2X7 Receptor Antagonists as Constrained Analogues of KN62
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Development of a Robust Synthesis of Dactolisib on a Commercial Manufacturing Scale

© 2014-2025 renovateindia.wappzo.com. All rights reserved.